Talk:Olanzapine
Appearance
This is the talk page for discussing improvements to the Olanzapine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 31 days |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Olanzapine.
|
Pharmacology B‑class High‑importance | ||||||||||
|
Medicine: Psychiatry B‑class High‑importance | |||||||||||||
|
/Archive 1 |
This page has archives. Sections older than 31 days may be automatically archived by Lowercase sigmabot III when more than 4 sections are present. |
NYT
Here's an important article that just came out in the NY Times http://www.nytimes.com/2006/12/18/business/18drug.html?hp&ex=1166504400&en=abbfa89f1f363c93&ei=5094&partner=homepage — Preceding unsigned comment added by 71.206.230.233 (talk)
Accidental injury?
What's up with that? Pubserv (talk) 19:28, 25 August 2013 (UTC)
NMS
Someone add Neuroleptic Malignant Syndrome to the side effects. Also, why does the Zyprexa talk page have so few entries compared to the Risperdal talk page? 78.156.109.166 (talk) 08:34, 24 October 2013 (UTC)
Zyprexa in popular culture
I added a rubric about zyprexa in popular culture like lithium and prozac have but it was deleted straightaway — Preceding unsigned comment added by 217.231.152.138 (talk) 14:49, 8 April 2014 (UTC)